Cargando…
Mifepristone in Fibroids: Comparative Study of Safety and Efficacy of Biweekly Dosage Vs Daily Dosage Schedule
BACKGROUND: Leiomyomas are the most prevalent benign tumors of the uterus and are seen more with increasing age. 50 mg biweekly dose was compared with 25 mg daily dose in terms of efficacy and safety in symptomatic women as the biweekly dose maybe an economically better alternative. Two different do...
Autores principales: | Shaikh, Neelofar, Mehra, Reeti, Goel, Poonam, Kaur, Ravinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189336/ https://www.ncbi.nlm.nih.gov/pubmed/34188425 http://dx.doi.org/10.4103/jmh.JMH_90_20 |
Ejemplares similares
-
Safety and effectiveness of different dosage of mifepristone for the treatment of uterine fibroids: a double-blind randomized clinical trial
por: Carbonell, Josep LL, et al.
Publicado: (2013) -
Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial
por: Liu, Chongdong, et al.
Publicado: (2017) -
Evaluation of Cyclophosphamide Dosage Schedules in Breast Cancer
por: Stoll, B. A.
Publicado: (1970) -
Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update
por: Segaert, Siegfried
Publicado: (2009) -
Conventional Versus Different Hypofractionated Radiotherapy Dosage Schedules in Postmastectomy Advanced Breast Cancer
por: Jain, Neeraj, et al.
Publicado: (2022)